Prognostic value of increased carbohydrate antigen in patients with heart failure

Table 3 Univariate analysis, variables significantly associated with need for hospitalization for decompensated heart failure

	Hospitalization	No hospitalization	P
LVEF (%)	48 ± 18	49 ± 17	0.7
IVS (mm)	12 ± 3	11 ± 3	0.14
LA (mm)	50 ± 9	48 ± 10	0.15
GF (MDRD)	56 ± 19	64 ± 21	0.01
Hemoglobin (g/L)	127 ± 22	132 ± 20	0.16
Na+ (mEq/mL)	139 ± 3.7	140 ± 3.6	0.4
K+ (mEq/mL)	4.2 ± 0.5	4.3 ± 0.6	0.3
Systolic BP (mmHg)	124 ± 18	125 ± 20	0.9
Diastolic BP (mmHg)	73 ± 11	72 ± 13	0.7
CA125 (KU/L)	58 ± 85	34 ± 61	0.01
NT-proBNP (pg/dL)	3431 ± 4792	2031 ± 3234	0.03
AF (%)	61	39	0.01
NYHA class III (%)	97	3	0.0001

LVEF: Left ventricular ejection fraction; IVS: Interventricular septum; LA: Left atrial; GF: Glomerular filtration; Na: Sodium; K: Potassium; BP: Blood pressure; CA125: Carbohydrate antigen 125; NT-proBNP: N-terminal pro-B-type natriuretic peptide; AF: Atrial fibrillation; NYHA: New York Heart Association.